Skip to main
MNTA
MNTA logo

Momenta Pharmaceuticals (MNTA) Earnings Dates & Reports

Momenta Pharmaceuticals (MNTA) Most Recent Earnings

Report DateAug 10, 2020
Period EndingQ2 2020
Est. EPS-$0.39
Actual EPS-$0.48
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Momenta Pharmaceuticals (MNTA) Earnings per Share (EPS) History

Signup for full access
Browse free

Momenta Pharmaceuticals (MNTA) Latest Earnings

The value each MNTA share was expected to gain vs. the value each share gained.

Momenta Pharmaceuticals (MNTA) reported its most recent earnings on Aug 10, 2020 for Q2 2020, posting earnings per share (EPS) of -$0.48. This exceeded analysts' expectations of -$0.39 by 23.08%, marking a Miss.

For comparison, Momenta Pharmaceuticals reported EPS of $0 in the same quarter last year.

The company is expected to announce its next earnings report on 08/10/2020, with analysts projecting an EPS of $0.

Momenta Pharmaceuticals (MNTA) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q2 2020Aug 10, 2020
-$0.39-$0.48+23.08%
DeckReportListen
Q1 2020May 7, 2020
-$0.48-$0.34-29.17%
DeckReportListen
Q4 2019Feb 26, 2020
-$0.56-$0.85+51.79%
DeckReportListen

Momenta Pharmaceuticals (MNTA) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Momenta Pharmaceuticals’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
May 7, 2020
Feb 26, 2020

Momenta Pharmaceuticals (MNTA) Earnings FAQs

Momenta Pharmaceuticals (MNTA) last reported earnings on Aug 10, 2020 for Q2 2020, posting an EPS of -$0.48, which Miss the estimate of -$0.39 by 23.08%.

For Q2 2020, Momenta Pharmaceuticals (MNTA) reported an EPS of -$0.48, missing analysts' estimate of -$0.39 by 23.08%.

For Q2 2020, Momenta Pharmaceuticals (MNTA) Miss expectations with an actual EPS of -$0.48 vs. an estimated EPS of -$0.39.

Following the last earnings report on Aug 10, 2020, Momenta Pharmaceuticals (MNTA)'s stock price moved — from — to —.

The next Momenta Pharmaceuticals (MNTA) earnings call is scheduled for Aug. 10, 2020, where executives will discuss financial results and outlook.

Momenta Pharmaceuticals (MNTA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.